Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(14%)
Results Posted
100%(3 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
2
29%
Ph early_phase_1
1
14%
Ph phase_2
2
29%
Ph phase_3
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 32 (28.6%)
N/A2 (28.6%)

Trials by Status

completed343%
terminated229%
active_not_recruiting114%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7